Atomo Diagnostics Limited (ASX:AT1) - Australian company, Atomo Diagnostics Limited (ASX:AT1) is a leading global provider of medical devices for blood-based rapid test, designed for professional use and self-test applications. Its innovative rapid diagnostic test (RDT) platforms are user friendly, simplifying procedures, improving test performance and mitigating common user errors. Atomo has supply agreements for test solutions targeting infectious diseases such as viral vs bacterial differentiation, COVID-19 and HIV.

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK